News
FDA asks Sarepta to stop shipping gene therapy
Digest more
Shares of Sarepta Therapeutics (NASDAQ:SRPT) continued to fall on Friday as Reuters reported that the U.S. FDA plans to ...
The favorable market reaction indicates investor relief at management’s swift measures to rectify the company's worsening ...
3d
Zacks Investment Research on MSNSRPT Stock Soars on Unveiling New Restructuring Plan, Pipeline PivotsShares of Sarepta Therapeutics SRPT surged more than 30% in after-market trading yesterday after the company announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results